Literature DB >> 9562497

Phosphorylation of tau, Abeta-formation, and apoptosis after in vivo inhibition of PP-1 and PP-2A.

T Arendt1, M Holzer, R Fruth, M K Brückner, U Gärtner.   

Abstract

Chronic inhibition of protein phosphatases 1 and 2A in vivo was induced by infusion of okadaic acid into lateral ventricles of rat brain for up to 4 months. Cytoskeletal pathology, alterations of the amyloid precursor protein, and apoptotic cell death induced by this treatment followed a certain sequence and spatial distribution. Changes in the expression, phosphorylation, and subcellular distribution of neurofilament proteins and tau, as well as first signs of apoptotic cell death, occurred already after about 2 weeks. The distribution of apoptotic cells, however, was different from those revealing a high accumulation of hyperphosphorylated tau, indicating that those cytoskeletal pathology had no obvious sequelae for the viability of these neurones. A continuation of treatment for longer than 2 weeks induced diffuse deposits of both hyperphosphorylated tau and A beta-amyloid-immunoreactive material in white matter areas that increased in size and number over time. Because tau-phosphorylation is a regulator of the dynamic stability of microtubules, the pathology observed in the present experimental paradigm in the white matter might be viewed as an indication of a disturbed axonal transport. It is hypothesized that perturbations of the axonal transport might also be critically involved in the formation of paired helical filaments and amyloid deposits in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9562497     DOI: 10.1016/s0197-4580(98)00003-7

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  14 in total

Review 1.  Neurotoxic and synaptic effects of okadaic acid, an inhibitor of protein phosphatases.

Authors:  R Tapia; F Peña; C Arias
Journal:  Neurochem Res       Date:  1999-11       Impact factor: 3.996

Review 2.  Neuroprotective effect of atypical antipsychotics in cognitive and non-cognitive behavioral impairment in animal models.

Authors:  Jue He; Jiming Kong; Qing-Rong Tan; Xin-Min Li
Journal:  Cell Adh Migr       Date:  2009-01-13       Impact factor: 3.405

3.  Inhibition of JNK by a peptide inhibitor reduces traumatic brain injury-induced tauopathy in transgenic mice.

Authors:  Hien T Tran; Laura Sanchez; David L Brody
Journal:  J Neuropathol Exp Neurol       Date:  2012-02       Impact factor: 3.685

Review 4.  Protein phosphatases and Alzheimer's disease.

Authors:  Steven P Braithwaite; Jeffry B Stock; Paul J Lombroso; Angus C Nairn
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

5.  Alterations in glucose metabolism induce hypothermia leading to tau hyperphosphorylation through differential inhibition of kinase and phosphatase activities: implications for Alzheimer's disease.

Authors:  Emmanuel Planel; Tomohiro Miyasaka; Thomas Launey; De-Hua Chui; Kentaro Tanemura; Shinji Sato; Ohoshi Murayama; Koichi Ishiguro; Yoshitaka Tatebayashi; Akihiko Takashima
Journal:  J Neurosci       Date:  2004-03-10       Impact factor: 6.167

6.  A new coumarin derivative, IMM-H004, attenuates okadaic acid-induced spatial memory impairment in rats.

Authors:  Xiu-yun Song; Ying-ying Wang; Shi-feng Chu; Jin-feng Hu; Peng-fei Yang; Wei Zuo; Lian-kun Song; Shuai Zhang; Nai-hong Chen
Journal:  Acta Pharmacol Sin       Date:  2016-02-01       Impact factor: 6.150

Review 7.  Cell "self-eating" (autophagy) mechanism in Alzheimer's disease.

Authors:  Sarah F Funderburk; Bridget K Marcellino; Zhenyu Yue
Journal:  Mt Sinai J Med       Date:  2010 Jan-Feb

Review 8.  Rodent models of neuroinflammation for Alzheimer's disease.

Authors:  Amir Nazem; Roman Sankowski; Michael Bacher; Yousef Al-Abed
Journal:  J Neuroinflammation       Date:  2015-04-17       Impact factor: 8.322

Review 9.  Is protein phosphatase inhibition responsible for the toxic effects of okadaic Acid in animals?

Authors:  Rex Munday
Journal:  Toxins (Basel)       Date:  2013-02-04       Impact factor: 4.546

Review 10.  Use of okadaic acid to identify relevant phosphoepitopes in pathology: a focus on neurodegeneration.

Authors:  Miguel Medina; Jesús Avila; Nieves Villanueva
Journal:  Mar Drugs       Date:  2013-05-21       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.